Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis B news

Show

From To
Hepatitis B Virus Elevates Risk for Age-Related Macular Degeneration

Those with hepatitis B virus have a significantly elevated risk for developing any type of age-related macular degeneration (AMD), according to a new report. It’s possible that hepatitis B virus may even accelerate the progression of AMD.

Published
14 March 2019
From
MD Magazine
Undiagnosed HBV, HCV, HIV prevalent in newly diagnosed cancer cases

Researchers discovered a substantial proportion of patients with newly diagnosed cancer and concurrent hepatitis C or hepatitis B were unaware of their viral infection and many had no identifiable risk factors, according to a recently published study.

Published
18 January 2019
From
Healio
Advanced fibrosis found in one-third of patients with HIV/HBV coinfection

Researchers observed significant fibrosis in more than one-third of patients with hepatitis B and HIV coinfection undergoing long-term combination antiretroviral therapy with viral suppression, according to a study published in American Journal of Gastroenterology.

Published
03 January 2019
From
Healio
Vosevi safe, effective in ‘triple-infected’ patients with HCV, HBV, HIV

The direct-acting antiviral Vosevi demonstrated an average sustained virologic response rate of 87% among patients who were “triple-infected” with hepatitis C genotype 3, hepatitis B and HIV, as presented at the American College of Gastroenterology Annual Meeting.

Published
15 October 2018
From
Healio
$20 blood test could help diagnose hepatitis B patients across Africa

Researchers have developed an accurate diagnostic score that consists of inexpensive blood tests to identify patients who require immediate treatment against the deadly hepatitis B virus -- which can lead to liver damage or cancer.

Published
02 July 2018
From
Science Daily
'Virus-cracking' molecules advance fight against hepatitis B

Researchers have found that certain molecules -- currently under clinical trial -- are able to 'crack' the protective shell of the hepatitis B virus, suggesting it may be possible to attack the virus after it has already taken hold in the body.

Published
07 February 2018
From
Science Daily
Gilead's hepatitis B therapy to vie with 20 Korean therapies

Korea has approved 20 products made by Korean companies targeting for No.1 chronic hepatitis B therapy Viread (compound: tenofovir disoproxil fumarate) made by Gilead.

Published
14 August 2017
From
Korea Biomedical Review
UK rations hepatitis B vaccine amid global shortage

Holidaymakers planning to travel abroad from the UK may not be able to get their jab in time, say experts.

Published
08 August 2017
From
BBC Health
Hepatitis B added to routine baby injections

All babies born from Tuesday in England, Wales and Northern Ireland will have an anti-hepatitis B injection added to the other routine vaccinations they are given in their early life. The jab protects against viral infections that cause cirrhosis and liver cancer.

Published
01 August 2017
From
BBC News
ECDC estimate: Around 9 million Europeans are affected by chronic hepatitis B or C

An estimated 4.7 million Europeans are living with chronic hepatitis B and almost 4 million with chronic hepatitis C infection. But large numbers of them are not aware of their infection as they have not yet been diagnosed. On of World Hepatitis Day, ECDC Director Andrea Ammon highlights the need for Europe to scale-up coverage of testing, prevention interventions and linkage to suitable treatment services to achieve the target of eliminating viral hepatitis by 2030.

Published
27 July 2017
From
Eurekalert Inf Dis
← First12345...10Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.